Expanded FDA regulation of health and wellness apps.
Bioethics
; 34(3): 235-241, 2020 03.
Article
en En
| MEDLINE
| ID: mdl-31633831
ABSTRACT
This paper argues that the Food and Drug Administration's (FDA) policy for health and wellness apps is ethically problematic. Currently, the FDA does not regulate health and wellness apps that are not intended for medical use. As a result of this hands-off policy, preventing harm to consumers is left primarily to developers and app marketplaces. We argue that the FDA's duties to prevent harm and maintain accountability to the American public require that they play a much stronger role. We also discuss concerns about efficiency and fostering innovation, and argue that while they should help shape FDA regulation of health and wellness apps, they do not justify complete absence of FDA involvement.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Seguridad de Productos para el Consumidor
/
Aplicaciones Móviles
/
Estilo de Vida Saludable
Aspecto:
Ethics
Límite:
Humans
País/Región como asunto:
America do norte
Idioma:
En
Revista:
Bioethics
Asunto de la revista:
ETICA
Año:
2020
Tipo del documento:
Article